Skymap Pharmaceuticals has been approved as the strategic buyer for IMPCL after emerging as the highest bidder with a ₹121 crore offer.
Read More
Think | Create | Scale
Most Commented News
Skymap Pharmaceuticals has been approved as the strategic buyer for IMPCL after emerging as the highest bidder with a ₹121 crore offer.
Read More